miR-1228 |
cancer-associated fibroblasts |
OS cells |
SCAI |
Promote OS cell migration and invasion |
(119) |
miR-148a-3p and miR-21–5p |
OS cells |
Raw264.7 and Huvec cells |
/ |
Influence osteoclast formation, tumor angiogenesis, and bone resorption |
(128) |
TGFβ2 |
Metastatic OS cells |
Tumor-associated macrophages |
/ |
Enhance M2 phenotype while creating the tumor-promoting, Immunosuppressive TME |
(129) |
TGFβ1 |
OS cells |
Resident lung cells |
/ |
Drive myofibroblast/cancer-associated |
(130) |
|
|
|
|
fibroblast differentiation |
|
Tim-3 |
MG63 |
Macrophages |
/ |
Induce M2 type differentiation of macrophages |
(131) |
COL6A1 |
OS cells |
cancer-associated fibroblasts |
IL-6, IL-8 and STAT1 |
Convert normal fibroblasts to cancer-associated fibroblasts |
(132) |
LIFR-AS1 |
Macrophages |
OS cells |
miR-29a/NFIA |
Enhance OS cell growth, invasion, and migration |
(133) |
|
|
|
|
While promoting their apoptosis |
|
miR-221–3p |
M2-polarized tumor-associated macrophages |
OS cells |
SOCS3/JAK2/STAT3 |
Promote growth of OS cells |
(134) |